Rizobacter

Companies like Verdesian Life Sciences and Rizobacter (part of Bioceres) dominate the seed treatment and nutrient use efficiency (NUE) space, offering high-concentration inoculants for broad-acre crops.

Country
Argentina
Commercial
Coverage
CNEUINUS
crop-biotech
Regulatorsusda-aphisepaefsa

Verifiable facts

FactValueSource
Funding$26.0 million public offering of Series V corporate bonds in the Argentine market (2021)investors.biocerescrops.com
Capacity50,000 tons per year for micro granulated fertilizers; 7.2 million liters per year for biological productsrizobacter.com.ar · rizobacter.com
CertificationISO 9001:2015, ISO 14001:2015, OHSAS 18001:2007 (Trinorm Certification)rizobacter.com.bo · rizobacter.com
Regulatory approval56 new international registrations obtained from March 2020 to present; registration for Rhizoliq TOP in China (2024)rizobacter.com · knoell.com
Production sitePergamino, Argentina (including Synertech Industries plant)rizobacter.com.ar · rizobacter.com
HeadcountApproximately 620-700 employees globallyrizobacter.com.ar · rizobacter.com
Revenue$197.8 million for the fiscal year ended June 30, 2025sec.gov

Independent sources: investors.biocerescrops.com · knoell.com · sec.gov

Technologies
NameClusterRisk
Nitrogen-fixing microbial inoculantscrop-biotechMedium

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.